Latest News

Alphamab Oncology Presents Phase 2 Clinical Data on KN046 Combined with Chemotherapy for the Treatment of Advanced NSCLC at ASCO 2021

* KN046 combined with platinum doublet chemotherapy is tolerated and has shown promising clinical benefit as IL treatment for stage IV NSCLC. * OS rate at 12 months and 15 months were both 74.9%; Similar survival was observed in patients with PD-L1≥1% and PD-L1<1%; * the median progression-f...

2021-06-07 10:10 6623

Tonik becomes PH's first neobank to secure digital bank license

MANILA, Philippines, June 7, 2021 /PRNewswire/ -- Tonik, the Philippines' first digital-only neobank continues to make waves in the local fintech and banking industry as it secures a digital bank license from the Bangko Sentral ng Pilipinas (BSP) – the first for any private and purely digital ba...

2021-06-07 10:00 3104

OriginCell Therapeutics Presents Positive Results of GPC3 CAR-T in HCC Trial at the 2021 ASCO Annual Meeting

SHANGHAI, June 7, 2021 /PRNewswire/ -- On June 4, 2021 (EST), OriginCell Therapeutics (Shanghai) Co., Ltd. ("OriginCell"), together with Lishui Central Hospital affiliated toZhejiang University and Shanghai Changzheng Hospital, presented the updated data from the on-going trial of Ori-CAR-001,...

2021-06-07 10:00 4496

Hyperice Named Official Recovery Technology Partner by League of Legends Pro League

SHANGHAI, June 7, 2021 /PRNewswire/ -- League of Legends Pro League (LPL) and  Hyperice, the industry leader in recovery technology and pioneer of percussion, vibration, dynamic air compression and thermal technology, today announced a partnership that names Hyperice the league's Official Recovery...

2021-06-07 10:00 3853

America's Fastest Growing Company Joined Australia in Alleviating the IT Talent Shortfall

HO CHI MINH CITY, Vietnam, June 7, 2021 /PRNewswire/ -- KMS Solutions has officially entered the Australian market after seeing more local enterprises reached out for its software engineering and digital team services. To ease the IT talent shortage that is plaguing Australia, KMS Solutions anno...

2021-06-07 10:00 3348

BIAL Award in Biomedicine worth 300,000 Euros, nominations until 30 June

PORTO, Portugal, June 7, 2021 /PRNewswire/ -- The second edition of the BIAL Award in Biomedicine is currently underway. Worth three hundred thousand Euros, this prize is intended to reward a work with exceptional quality results and scientific relevance published in the last ten years in the bro...

2021-06-07 10:00 1784

Poster Highlighting Clinical Data of KN046 Plus Nab-Paclitaxel/Gemcitabine as First-Line Treatment for Pancreatic Cancer Is Presented at ASCO 2021

* As of January 15, 2021, 9 patients were included in the efficacy analysis and 17 patients in the safety analysis. ORR was 55.6%, and DCR was 88.9%. * The updated results from this Phase II study will be presented at an upcoming medical meeting. A phase III clinical study of KN046 in combinat...

2021-06-07 09:53 6658

CSOP Asset Management Ltd. Chooses SS&C to Support Operations

WINDSOR, Conn., June 7, 2021 /PRNewswire/ -- SS&C Technologies Holdings, Inc. (Nasdaq: SSNC) today announced thatHong Kong's CSOP Asset Management Ltd. has selected Eze Investment Suite for order management and portfolio accounting. Eze Investment Suite provides the flexibility CSOP required for ...

2021-06-07 09:00 11181

Trip.com Group joins the United Nations Global Compact

SINGAPORE, June 7, 2021 /PRNewswire/ -- Trip.com Group, leading global travel services provider, has joined the United Nations Global Compact to inspire change. Since 17th May 2021, Trip.com Group has been committed to the UN Global Compact corporate responsibility initiative and its principles i...

2021-06-07 09:00 3676

BenQ Launches World's First 4K HDR 16ms Gaming Projector, Cements No.1 Market Share in 4K Projector Segment

SINGAPORE, June 7, 2021 /PRNewswire/ -- BenQ, the global No.1 DLP projector brand, today launched a brand-new gaming projector segment with the new TK700STi 4K Gaming Projector, bringing users the unprecedented combination of 4K resolution at 16ms low input lag for a premium all-in-one entertainme...

2021-06-07 09:00 3051

WeBank and SMU Nurture Future-Ready Fintech Talent with Blockchain Courses

SHENZHEN, China, June 7, 2021 /PRNewswire/ -- WeBank, the world's leading digital bank and the first digital-only bank inChina, announced that its summer enrichment programme onFISCO BCOS[1] Blockchain Experience at the Singapore Management University (SMU), a premier university in Asia internati...

2021-06-07 09:00 4192

Ascletis Received China IND Approval of Its FXR Agonist ASC42 for Chronic Hepatitis B Indication

HANGZHOU, China and SHAOXING, China, June 7, 2021 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672) today announces that China National Medical Products Administration (NMPA) has approved the Investigational New Drug (IND) application for its drug candidate ASC42 to conduct clinical trials for ch...

2021-06-07 08:30 3987

Innovent Releases Phase 1 Results of Pemigatinib in Chinese Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021

SAN FRANCISCO and SUZHOU, China, June 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-06-07 08:00 8619

Innovent Releases the Phase Ia/Ib Dose-Escalation Trial Results of IBI110 (anti-LAG-3) in Patients with Advanced Solid Tumors at ASCO Annual Meeting 2021

SAN FRANCISCO and SUZHOU, China, June 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-06-07 08:00 8704

Innovent and AnHeart Release Preliminary Results from the Phase II TRUST Trial of Taletrectinib in ROS1 Fusion Positive NSCLC at the ASCO 2021 Annual Meeting

SAN FRANCISCO and SUZHOU, China, June 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-06-07 08:00 8607

Innovent and HUTCHMED Release Phase 1b preliminary Results of TYVYT (Sintilimab Injection) plus Fruquintinib as a Third Line Treatment for Advanced Colorectal Cancer at ASCO Annual Meeting 2021

SAN FRANCISCO and SUZHOU, China, June 7, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent", HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseas...

2021-06-07 08:00 8513

Arctic Vision Announces Exclusive Licensing Agreement with Olympic Ophthalmics for iTEAR®100 for the Treatment of Dry Eye Disease in Greater China, South Korea and ASEAN countries

ISSAQUAH, Wash. and SHANGHAI, June 7, 2021 /PRNewswire/ -- Arctic Vision, a clinical stage biotech company focusing on innovative ophthalmology therapies for pan-ocular diseases, and Olympic Ophthalmics, a U.S.-based medical technology company pioneering neuromodulation treatments for ophthalmic ...

2021-06-07 08:00 2745

The Classroom Door (TCD) Launches Global Educational Platform Bringing Together Expert Tutors, Advisors And Proprietary College Counseling Content

Woman-owned virtual tutoring and college counseling marketplace to bring equity and access to all students MIAMI, June 7, 2021 /PRNewswire/ -- The Classroom Door (TCD), a comprehensive global educational platform and tutoring marketplace that provides access to world-class tutors, certified teac...

2021-06-07 08:00 1532

Ian Schrager Relaunches His Transformative New Brand Public for A New Beginning for Both the Hotel and New York City

NEW YORK, June 7, 2021 /PRNewswire/ -- It is not often in life, if ever, that you have a once in a lifetime opportunity to be involved in something really special, and yet have a second chance to rethink, refine and improve upon what was previously done. This unprecedented period of madness has g...

2021-06-07 07:30 3147

Earlytrade Report: Govt support not enough for traumatised Melbourne businesses entering extended lockdown

MELBOURNE, Australia, June 7, 2021 /PRNewswire/ -- Melbourne business owners have recorded a surge in demand for early invoice payments indicating that new government support measures may not be enough. Data released by Australia's largest supplier payments platform, Earlytrade - which allows su...

2021-06-07 07:22 2041